Earth's simplest and smallest animals rocket into space for cancer research

byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m

Updated on: December 20,2023

Earth's simplest and smallest animals rocket into space for cancer research

byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m

Updated on:December 20,2023

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on: March 30,2025

New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma

Updated on:March 30,2025

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on: January 04,2024

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on:January 04,2024

Normalizing tumor blood vessels may improve immunotherapy against brain cancer

by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev

Updated on: January 04,2024

Normalizing tumor blood vessels may improve immunotherapy against brain cancer

by Noah Brown,Massachusetts General HospitalAnti-VEGF treatment improves the efficacy of EGFRvIII-CAR-T cells in murine GBM tumor models. (A) Schematic representation of experimental setup to ev

Updated on:January 04,2024

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on: December 26,2023

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on:December 26,2023

Scientists uncover potential 'electrical language' of breast cancer cells

by Caroline Brogan,Imperial College LondonA wave of voltage fluctuations seen across the cells. Credit: Imperial College LondonNew research has found variable voltages in the membranes of breast

Updated on: December 27,2023

Scientists uncover potential 'electrical language' of breast cancer cells

by Caroline Brogan,Imperial College LondonA wave of voltage fluctuations seen across the cells. Credit: Imperial College LondonNew research has found variable voltages in the membranes of breast

Updated on:December 27,2023

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin

Updated on: December 18,2023

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin

Updated on:December 18,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on: December 27,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on:December 27,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK

Updated on: January 04,2024

Chemotherapy before surgery cuts risk of colon cancer returning, trial finds

byCancer Research UKCredit: CC0 Public DomainGiving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to the results of a Cancer Research UK

Updated on:January 04,2024

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on: January 08,2024

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on:January 08,2024